CIK 0001660334 · Non-accelerated filer<br>Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463137900
- Phone
- 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $109,690
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$109,690. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | Kirby John J. Interim CFO | Purchase | +3,536 | $4.24 | $15K | 8,962 |
| 2025-11-25 | Kirby John J. Interim CFO | Purchase · Series C Warrant (right to buy) | +884 | 884 | ||
| 2025-11-25 | Manning Paul B Director | Purchase | +1,375,380 | $4.24 | $5.8M | 3,958,189 |
| 2025-11-25 | Manning Paul B Director | Purchase | +2,750,762 | $4.24 | $11.7M | 3,348,372 |
| 2025-11-25 | Manning Paul B Director | Purchase · Series C Warrant (right to buy) | +343,845 | 343,845 | ||
| 2025-11-25 | Manning Paul B Director | Purchase · Series C Warrant (right to buy) | +687,690 | 687,690 | ||
| 2025-06-05 | Corcoran Gavin Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-05 | PRYGOCKI MARK A SR Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-05 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-05 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-03-31 | Corcoran Gavin Director | Grant or award · Stock Option (right to buy) | +17,502 | 17,502 | ||
| 2025-03-24 | Rosenberg Noah L. CMO | Grant or award · Employee Stock Option (right to buy) | +325,000 | 325,000 | ||
| 2025-03-17 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | −4,315 | $0.65 | $3K | 176,458 |
| 2025-03-14 | Rieger Jayson CEO and President | Grant or award · Employee Stock Option (right to buy) | +850,000 | 850,000 | ||
| 2025-03-14 | Hayes Christopher G. CHIEF LEGAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-12-09 | Zawitz David Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +950,000 | 950,000 | ||
| 2024-11-26 | Rieger Jayson CEO and President | Gift | +50,000 | 882,826 | ||
| 2024-11-26 | Stalfort John A III Director | Gift | +50,000 | 1,873,800 | ||
| 2024-11-26 | Manning Paul B Director | Gift | −450,000 | 25,828,094 | ||
| 2024-11-22 | Rieger Jayson CEO and President | Purchase | +280,898 | 832,826 |
Page 2 of 8 · 154 trades